Cell, ISSN 0092-8674, 11/2017, Volume 171, Issue 6, pp. 1437 - 1452.e17
We previously piloted the concept of a Connectivity Map (CMap), whereby genes, drugs, and disease states are connected by virtue of common gene-expression...
chemical biology | gene expression profiling | Functional genomics | UBIQUITINATION | LUNG-CANCER | DEL(5Q) MDS | INHIBITION | PATHWAY | BIOCHEMISTRY & MOLECULAR BIOLOGY | PHA-793887 | GENE-EXPRESSION | ACQUIRED-RESISTANCE | DEGRADATION | DISCOVERY | CELL BIOLOGY | Sequence Analysis, RNA - methods | Pharmaceutical Preparations - metabolism | Small Molecule Libraries | Humans | Cell Line, Tumor | Drug Resistance, Neoplasm | Gene Expression Profiling - economics | Gene Expression Profiling - methods | Sequence Analysis, RNA - economics | Organ Specificity | Neoplasms - drug therapy | RNA sequencing | Gene expression | Genes
chemical biology | gene expression profiling | Functional genomics | UBIQUITINATION | LUNG-CANCER | DEL(5Q) MDS | INHIBITION | PATHWAY | BIOCHEMISTRY & MOLECULAR BIOLOGY | PHA-793887 | GENE-EXPRESSION | ACQUIRED-RESISTANCE | DEGRADATION | DISCOVERY | CELL BIOLOGY | Sequence Analysis, RNA - methods | Pharmaceutical Preparations - metabolism | Small Molecule Libraries | Humans | Cell Line, Tumor | Drug Resistance, Neoplasm | Gene Expression Profiling - economics | Gene Expression Profiling - methods | Sequence Analysis, RNA - economics | Organ Specificity | Neoplasms - drug therapy | RNA sequencing | Gene expression | Genes
Journal Article
Human Reproduction, ISSN 0268-1161, 06/2013, Volume 28, Issue suppl_1, pp. i149 - i206
Journal Article
Human Reproduction, ISSN 0268-1161, 06/2013, Volume 28, Issue suppl_1, pp. i311 - i356
Journal Article
Human Reproduction, ISSN 0268-1161, 07/2012, Volume 27, Issue suppl_2, pp. ii162 - ii205
Journal Article
HUMAN REPRODUCTION, ISSN 0268-1161, 08/2016, Volume 31, Issue 8, pp. 1638 - 1652
The 16th European IVF-monitoring (EIM) report presents the data of the treatments involving assisted reproductive technology (ART) and intrauterine...
frozen embryo replacement | registry | ICSI | REPRODUCTIVE BIOLOGY | intrauterine insemination | Europe | IVF | egg donation | data collection | TRENDS | SPERM INJECTION | OBSTETRICS & GYNECOLOGY
frozen embryo replacement | registry | ICSI | REPRODUCTIVE BIOLOGY | intrauterine insemination | Europe | IVF | egg donation | data collection | TRENDS | SPERM INJECTION | OBSTETRICS & GYNECOLOGY
Journal Article
Nature Medicine, ISSN 1078-8956, 04/2017, Volume 23, Issue 4, pp. 405 - 408
 Drug repurposing, the application of an existing therapeutic to a new disease indication, holds promise of rapid clinical impact at a lower cost than de novo...
MEDICINE, RESEARCH & EXPERIMENTAL | DATABASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENES | CELL BIOLOGY | Databases, Pharmaceutical | Pharmaceutical Preparations | Drug Repositioning | Internet | Pharmaceutical research | Technology application | Forecasts and trends | Libraries | Disease | Drug therapy | Information dissemination
MEDICINE, RESEARCH & EXPERIMENTAL | DATABASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENES | CELL BIOLOGY | Databases, Pharmaceutical | Pharmaceutical Preparations | Drug Repositioning | Internet | Pharmaceutical research | Technology application | Forecasts and trends | Libraries | Disease | Drug therapy | Information dissemination
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 2018, Volume 24, Issue 18, pp. 1972 - 1989
Commonly, the angiogenic growth factors signify healing. However, gastrointestinal ulceration is still poorly understood particularly with respect to a general...
Ligament and bone healing | Gastrointestinal healing | VEGF | Pentadecapeptide BPC 157 | Angiogenic growth factors | Tendon | ULCERATIVE-COLITIS | pentadecapeptide BPC 157 | COLONIC ANASTOMOSES | FACTOR-I | INCREASED VASCULAR-PERMEABILITY | SKELETAL-MUSCLE | tendon | PLATELET-RICH PLASMA | INFLAMMATORY-BOWEL-DISEASE | ligament and bone healing | gastrointestinal healing | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | GASTRIC PENTADECAPEPTIDE BPC-157 | MOLECULAR-MECHANISMS
Ligament and bone healing | Gastrointestinal healing | VEGF | Pentadecapeptide BPC 157 | Angiogenic growth factors | Tendon | ULCERATIVE-COLITIS | pentadecapeptide BPC 157 | COLONIC ANASTOMOSES | FACTOR-I | INCREASED VASCULAR-PERMEABILITY | SKELETAL-MUSCLE | tendon | PLATELET-RICH PLASMA | INFLAMMATORY-BOWEL-DISEASE | ligament and bone healing | gastrointestinal healing | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | GASTRIC PENTADECAPEPTIDE BPC-157 | MOLECULAR-MECHANISMS
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 2018, Volume 24, Issue 18, pp. 1990 - 2001
Years ago, we revealed a novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157, particular anti-ulcer peptide that heals different organs...
Endothelium protection | Stable gastric pentadecapeptide BPC 157 | Organoprotection | Stomach cells protection | Control of blood vessels function | Cytoprotection | L-NAME | cytoprotection | NO-SYSTEM | 16,16-DIMETHYL PROSTAGLANDIN-E2 | stomach cells protection | BOWEL-DISEASE PL-10 | ALCOHOL-DRINKING RATS | control of blood vessels function | ARGININE METHYL-ESTER | PL 14736 | organoprotection | RESTRAINT STRESS | endothelium protection | ANTIULCER AGENTS | PHARMACOLOGY & PHARMACY | ADAPTIVE CYTOPROTECTION
Endothelium protection | Stable gastric pentadecapeptide BPC 157 | Organoprotection | Stomach cells protection | Control of blood vessels function | Cytoprotection | L-NAME | cytoprotection | NO-SYSTEM | 16,16-DIMETHYL PROSTAGLANDIN-E2 | stomach cells protection | BOWEL-DISEASE PL-10 | ALCOHOL-DRINKING RATS | control of blood vessels function | ARGININE METHYL-ESTER | PL 14736 | organoprotection | RESTRAINT STRESS | endothelium protection | ANTIULCER AGENTS | PHARMACOLOGY & PHARMACY | ADAPTIVE CYTOPROTECTION
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 2013, Volume 19, Issue 1, pp. 76 - 83
Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, proven in clinical trials to be both safe in inflammatory bowel disease (PL-10,...
NSAIDs-liver lesions | Thrombocytopenia | NSAIDs-gastrointestinal tract lesions | Counteraction | NSAIDs-brain lesions | Antidote against NSAIDs | Aspirin-prolonged bleeding | Stable gastric pentadecapeptide BPC 157 | DUODENAL-ULCER | COLOCUTANEOUS FISTULAS | ACUTE LIVER-INJURY | counteraction | stable gastric pentadecapeptide BPC 157 | antidote against NSAIDs | ALCOHOL-DRINKING RATS | PROSTAGLANDIN SYNTHETASE | aspirin-prolonged bleeding/ thrombocytopenia | RESTRAINT STRESS | SHORT-BOWEL SYNDROME | ACETAMINOPHEN OVERDOSE | ANTIULCER AGENTS | PHARMACOLOGY & PHARMACY | ADAPTIVE CYTOPROTECTION | Antidotes - pharmacology | Anti-Ulcer Agents - therapeutic use | Brain - physiopathology | Humans | Anti-Ulcer Agents - adverse effects | Gastrointestinal Tract - physiopathology | Gastrointestinal Tract - drug effects | Peptide Fragments - pharmacology | Liver - physiopathology | Brain - drug effects | Proteins - therapeutic use | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Liver - drug effects | Aspirin - adverse effects | Proteins - adverse effects | Anti-Ulcer Agents - pharmacology | Antidotes - adverse effects | Peptide Fragments - adverse effects | Peptide Fragments - therapeutic use | Proteins - pharmacology | Antidotes - therapeutic use
NSAIDs-liver lesions | Thrombocytopenia | NSAIDs-gastrointestinal tract lesions | Counteraction | NSAIDs-brain lesions | Antidote against NSAIDs | Aspirin-prolonged bleeding | Stable gastric pentadecapeptide BPC 157 | DUODENAL-ULCER | COLOCUTANEOUS FISTULAS | ACUTE LIVER-INJURY | counteraction | stable gastric pentadecapeptide BPC 157 | antidote against NSAIDs | ALCOHOL-DRINKING RATS | PROSTAGLANDIN SYNTHETASE | aspirin-prolonged bleeding/ thrombocytopenia | RESTRAINT STRESS | SHORT-BOWEL SYNDROME | ACETAMINOPHEN OVERDOSE | ANTIULCER AGENTS | PHARMACOLOGY & PHARMACY | ADAPTIVE CYTOPROTECTION | Antidotes - pharmacology | Anti-Ulcer Agents - therapeutic use | Brain - physiopathology | Humans | Anti-Ulcer Agents - adverse effects | Gastrointestinal Tract - physiopathology | Gastrointestinal Tract - drug effects | Peptide Fragments - pharmacology | Liver - physiopathology | Brain - drug effects | Proteins - therapeutic use | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Liver - drug effects | Aspirin - adverse effects | Proteins - adverse effects | Anti-Ulcer Agents - pharmacology | Antidotes - adverse effects | Peptide Fragments - adverse effects | Peptide Fragments - therapeutic use | Proteins - pharmacology | Antidotes - therapeutic use
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 2012, Volume 19, Issue 1, pp. 126 - 132
Stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, M. W. 1419) may be the new drug stable in human gastric juice, effective both in the upper and lower...
Colocutaneous fistulas | Inflammatory bowel disease | Short bowel | BPC 157 | Intestinal anastomosis | CHEMISTRY, MEDICINAL | short bowel | BIOCHEMISTRY & MOLECULAR BIOLOGY | ACHILLES-TENDON | colocutaneous fistulas | CYSTEAMINE-COLON | ALCOHOL-DRINKING RATS | EFFECTIVE THERAPY | inflammatory bowel disease | PL 14736 | RESTRAINT STRESS | PROLONGED ESOPHAGITIS | INFLAMMATORY-BOWEL-DISEASE | INTESTINAL ADAPTATION | intestinal anastomosis | PHARMACOLOGY & PHARMACY | GROWTH-FACTOR | Proteins - therapeutic use | Intestinal Diseases - drug therapy | Anti-Ulcer Agents - therapeutic use | Peptide Fragments - therapeutic use | Animals | Humans
Colocutaneous fistulas | Inflammatory bowel disease | Short bowel | BPC 157 | Intestinal anastomosis | CHEMISTRY, MEDICINAL | short bowel | BIOCHEMISTRY & MOLECULAR BIOLOGY | ACHILLES-TENDON | colocutaneous fistulas | CYSTEAMINE-COLON | ALCOHOL-DRINKING RATS | EFFECTIVE THERAPY | inflammatory bowel disease | PL 14736 | RESTRAINT STRESS | PROLONGED ESOPHAGITIS | INFLAMMATORY-BOWEL-DISEASE | INTESTINAL ADAPTATION | intestinal anastomosis | PHARMACOLOGY & PHARMACY | GROWTH-FACTOR | Proteins - therapeutic use | Intestinal Diseases - drug therapy | Anti-Ulcer Agents - therapeutic use | Peptide Fragments - therapeutic use | Animals | Humans
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 2014, Volume 20, Issue 7, pp. 1126 - 1135
We reviewed stable gastric pentadecapeptide BPC 157-NO-system-relation, its close participation in Moncada's (maintained vascular integrity, platelets control)...
Thrombocytopenia | Chronic heart failure | Thrombosis | Arrhythmias | Pentadecapeptide BPC 157 | Pulmonary hypertension | Chronic Heart Failure | NITRIC-OXIDE SYNTHASE | ULCERATIVE-COLITIS | BOWEL-DISEASE PL-10 | ALCOHOL-DRINKING RATS | 157 PL 14736 | EFFECTIVE THERAPY | L-ARGININE | ENDOTHELIAL-CELLS | ETHANOL-WITHDRAWAL | PHARMACOLOGY & PHARMACY | Pulmonary Hypertension | CONGESTIVE-HEART-FAILURE | Proteins - physiology | Cardiovascular Diseases - drug therapy | Humans | Peptide Fragments - pharmacology | Peptide Fragments - physiology | Proteins - therapeutic use | Animals | Gastric Mucosa - physiology | Gastric Mucosa - drug effects | Gastric Mucosa - physiopathology | Peptide Fragments - therapeutic use | Proteins - pharmacology | Wound Healing - physiology | Nitric Oxide - metabolism | Wound Healing - drug effects | Disease Models, Animal
Thrombocytopenia | Chronic heart failure | Thrombosis | Arrhythmias | Pentadecapeptide BPC 157 | Pulmonary hypertension | Chronic Heart Failure | NITRIC-OXIDE SYNTHASE | ULCERATIVE-COLITIS | BOWEL-DISEASE PL-10 | ALCOHOL-DRINKING RATS | 157 PL 14736 | EFFECTIVE THERAPY | L-ARGININE | ENDOTHELIAL-CELLS | ETHANOL-WITHDRAWAL | PHARMACOLOGY & PHARMACY | Pulmonary Hypertension | CONGESTIVE-HEART-FAILURE | Proteins - physiology | Cardiovascular Diseases - drug therapy | Humans | Peptide Fragments - pharmacology | Peptide Fragments - physiology | Proteins - therapeutic use | Animals | Gastric Mucosa - physiology | Gastric Mucosa - drug effects | Gastric Mucosa - physiopathology | Peptide Fragments - therapeutic use | Proteins - pharmacology | Wound Healing - physiology | Nitric Oxide - metabolism | Wound Healing - drug effects | Disease Models, Animal
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 06/2011, Volume 17, Issue 16, pp. 1612 - 1632
Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, safe in inflammatory bowel disease clinical trials (GEPPPGKPADDAGLV, M. W. 1419, PL...
Periodontal | Hepatic | Esophageal | Duodenal | Gastric | Stable gastric pentadecapeptide BPC 157 | Pancreatic lesion | Intestinal | esophageal | gastric | DUODENAL-ULCER | stable gastric pentadecapeptide BPC 157 | ALCOHOL-DRINKING RATS | PL 14736 | intestinal | RESTRAINT STRESS | PROLONGED ESOPHAGITIS | duodenal | INFLAMMATORY-BOWEL-DISEASE | pancreatic lesion | hepatic | ANTIULCER AGENTS | PHARMACOLOGY & PHARMACY | ACUTE-PANCREATITIS | ADAPTIVE CYTOPROTECTION | DOPAMINE AGONISTS | Proteins - therapeutic use | Anti-Ulcer Agents - therapeutic use | Animals | Gastrointestinal Diseases - drug therapy | Humans | Rats | Peptide Fragments - therapeutic use
Periodontal | Hepatic | Esophageal | Duodenal | Gastric | Stable gastric pentadecapeptide BPC 157 | Pancreatic lesion | Intestinal | esophageal | gastric | DUODENAL-ULCER | stable gastric pentadecapeptide BPC 157 | ALCOHOL-DRINKING RATS | PL 14736 | intestinal | RESTRAINT STRESS | PROLONGED ESOPHAGITIS | duodenal | INFLAMMATORY-BOWEL-DISEASE | pancreatic lesion | hepatic | ANTIULCER AGENTS | PHARMACOLOGY & PHARMACY | ACUTE-PANCREATITIS | ADAPTIVE CYTOPROTECTION | DOPAMINE AGONISTS | Proteins - therapeutic use | Anti-Ulcer Agents - therapeutic use | Animals | Gastrointestinal Diseases - drug therapy | Humans | Rats | Peptide Fragments - therapeutic use
Journal Article
Life Sciences, ISSN 0024-3205, 03/2016, Volume 148, pp. 63 - 70
Rectovaginal fistula is a devastating condition providing more than 99% of patients for surgical treatment. We hypothesized that rectovaginal fistula may be...
Rats | Healing | Rectovaginal fistula | BPC 157 | MEDICINE, RESEARCH & EXPERIMENTAL | TENDON | ANGIOGENESIS | ANASTOMOSIS | IN-VITRO | THERAPY | COLITIS | PL14736 | PHARMACOLOGY & PHARMACY | MICE | EXPRESSION | BPC-157 | Rectovaginal Fistula - drug therapy | Anti-Ulcer Agents - therapeutic use | Rectovaginal Fistula - pathology | Rats, Wistar | Peptide Fragments - pharmacology | Proteins - therapeutic use | Animals | Anti-Ulcer Agents - pharmacology | Female | Peptide Fragments - therapeutic use | Proteins - pharmacology | Wound Healing - drug effects | Fistula
Rats | Healing | Rectovaginal fistula | BPC 157 | MEDICINE, RESEARCH & EXPERIMENTAL | TENDON | ANGIOGENESIS | ANASTOMOSIS | IN-VITRO | THERAPY | COLITIS | PL14736 | PHARMACOLOGY & PHARMACY | MICE | EXPRESSION | BPC-157 | Rectovaginal Fistula - drug therapy | Anti-Ulcer Agents - therapeutic use | Rectovaginal Fistula - pathology | Rats, Wistar | Peptide Fragments - pharmacology | Proteins - therapeutic use | Animals | Anti-Ulcer Agents - pharmacology | Female | Peptide Fragments - therapeutic use | Proteins - pharmacology | Wound Healing - drug effects | Fistula
Journal Article
Journal of Postgraduate Medicine, ISSN 0022-3859, 10/2012, Volume 58, Issue 4, pp. 298 - 300
The most common casues of acute abdomen during pregnancy are acute appendicitis followed by acute cholecystitis. The case presented is a 33-year-old patient in...
laparoscopy | in vitro fertilization | tocolysis | Cholecystitis | pregnancy | HETEROTOPIC PREGNANCY | MEDICINE, GENERAL & INTERNAL | ABSCESS | APPENDICITIS | Case studies | Cholecystectomy | Fertilization in vitro | Care and treatment | Demographic aspects | Transplantation | Human embryo | In vitro fertilization | Abdominal surgery | Gallbladder diseases
laparoscopy | in vitro fertilization | tocolysis | Cholecystitis | pregnancy | HETEROTOPIC PREGNANCY | MEDICINE, GENERAL & INTERNAL | ABSCESS | APPENDICITIS | Case studies | Cholecystectomy | Fertilization in vitro | Care and treatment | Demographic aspects | Transplantation | Human embryo | In vitro fertilization | Abdominal surgery | Gallbladder diseases
Journal Article
Journal of Perinatal Medicine, ISSN 0300-5577, 02/2007, Volume 35, Issue 1, pp. 10 - 27
Aim: The purpose of this paper is to review and analyze the published literature on the use of three-dimensional (3DUS) and four-dimensional (4DUS) ultrasound...
Four-dimensional ultrasound | Obstetric ultrasound, three-dimensional ultrasound | Clinical application | clinical application | four-dimensional ultrasound | 3-DIMENSIONAL POWER DOPPLER | three-dimensional ultrasound | SONOGRAPHIC ASSESSMENT | obstetric ultrasound | OBSTETRICS & GYNECOLOGY | 4-DIMENSIONAL FETAL ECHOCARDIOGRAPHY | NORMAL PREGNANCIES | SPATIOTEMPORAL IMAGE CORRELATION | CONGENITAL HEART-DISEASE | METOPIC SUTURE | PEDIATRICS | CHROMOSOMALLY ABNORMAL FETUSES | NUCHAL TRANSLUCENCY | PRENATAL-DIAGNOSIS | Pregnancy | Fetus - abnormalities | Maternal-Fetal Relations | Neonatology - methods | Ultrasonography, Prenatal | Humans | Female | Imaging, Three-Dimensional | Fetus - physiology | Perinatology - methods
Four-dimensional ultrasound | Obstetric ultrasound, three-dimensional ultrasound | Clinical application | clinical application | four-dimensional ultrasound | 3-DIMENSIONAL POWER DOPPLER | three-dimensional ultrasound | SONOGRAPHIC ASSESSMENT | obstetric ultrasound | OBSTETRICS & GYNECOLOGY | 4-DIMENSIONAL FETAL ECHOCARDIOGRAPHY | NORMAL PREGNANCIES | SPATIOTEMPORAL IMAGE CORRELATION | CONGENITAL HEART-DISEASE | METOPIC SUTURE | PEDIATRICS | CHROMOSOMALLY ABNORMAL FETUSES | NUCHAL TRANSLUCENCY | PRENATAL-DIAGNOSIS | Pregnancy | Fetus - abnormalities | Maternal-Fetal Relations | Neonatology - methods | Ultrasonography, Prenatal | Humans | Female | Imaging, Three-Dimensional | Fetus - physiology | Perinatology - methods
Journal Article
Digestive Diseases and Sciences, ISSN 0163-2116, 10/2009, Volume 54, Issue 10, pp. 2070 - 2083
The gastric pentadecapeptide BPC 157, which was shown to be safe as an antiulcer peptide in trials for inflammatory bowel disease (PL14736, Pliva),...
Rats | Gastric pentadecapeptide BPC 157 | Short bowel syndrome | COLONIC ANASTOMOSES | CYSTEAMINE-COLON | EFFECTIVE THERAPY | INCISIONAL WOUNDS | RESTRAINT STRESS | PROLONGED ESOPHAGITIS | INTESTINAL ADAPTATION | EPIDERMAL-GROWTH-FACTOR | ANTIULCER AGENTS | GASTROENTEROLOGY & HEPATOLOGY | ADAPTIVE CYTOPROTECTION | Anti-Ulcer Agents - therapeutic use | Intestine, Small - pathology | Rats, Wistar | Male | Peptide Fragments - pharmacology | Random Allocation | Proteins - therapeutic use | Animals | Short Bowel Syndrome - drug therapy | Anti-Ulcer Agents - pharmacology | Peptide Fragments - therapeutic use | Proteins - pharmacology | Peptides | Malabsorption syndromes | Valves
Rats | Gastric pentadecapeptide BPC 157 | Short bowel syndrome | COLONIC ANASTOMOSES | CYSTEAMINE-COLON | EFFECTIVE THERAPY | INCISIONAL WOUNDS | RESTRAINT STRESS | PROLONGED ESOPHAGITIS | INTESTINAL ADAPTATION | EPIDERMAL-GROWTH-FACTOR | ANTIULCER AGENTS | GASTROENTEROLOGY & HEPATOLOGY | ADAPTIVE CYTOPROTECTION | Anti-Ulcer Agents - therapeutic use | Intestine, Small - pathology | Rats, Wistar | Male | Peptide Fragments - pharmacology | Random Allocation | Proteins - therapeutic use | Animals | Short Bowel Syndrome - drug therapy | Anti-Ulcer Agents - pharmacology | Peptide Fragments - therapeutic use | Proteins - pharmacology | Peptides | Malabsorption syndromes | Valves
Journal Article
17.
Full Text
Gynecol Endocrinol: Follicular progesterone elevations with ovulation induction for IVF
Croatian Medical Journal, ISSN 0353-9504, 06/2014, Volume 55, Issue 3, p. 285
Journal Article
Journal of Pharmacological Sciences, ISSN 1347-8613, 2008, Volume 108, Issue 1, pp. 7 - 17
We focused on the therapeutic effect of the stable gastric pentadecapeptide BPC 157 and how its action is related to nitric oxide (NO) in persistent...
skin defect | stable gastric pentadecapeptide BPC 157 | colon defect | colocutaneous fistula | Skin defect | Stable gastric pentadecapeptide BPC 157 | Colocutaneous fistula | Colon defect | CYSTEAMINE | ULCERATIVE-COLITIS | ARGININE METHYL-ESTER | LESIONS | RESTRAINT STRESS | ANASTOMOSIS | PROLONGED ESOPHAGITIS | GASTRIC PENTADECAPEPTIDE | BPC 157 | WOUNDS | PHARMACOLOGY & PHARMACY | Inflammatory Bowel Diseases - drug therapy | NG-Nitroarginine Methyl Ester - pharmacology | Anti-Ulcer Agents - therapeutic use | Nitric Oxide - biosynthesis | Rats, Wistar | Enzyme Inhibitors - pharmacology | Nitric Oxide Synthase - antagonists & inhibitors | Rats | Male | Nitric Oxide - physiology | Proteins - therapeutic use | Cutaneous Fistula - drug therapy | Animals | Arginine - pharmacology | Anesthesia | Colonic Diseases - drug therapy | Peptide Fragments - therapeutic use
skin defect | stable gastric pentadecapeptide BPC 157 | colon defect | colocutaneous fistula | Skin defect | Stable gastric pentadecapeptide BPC 157 | Colocutaneous fistula | Colon defect | CYSTEAMINE | ULCERATIVE-COLITIS | ARGININE METHYL-ESTER | LESIONS | RESTRAINT STRESS | ANASTOMOSIS | PROLONGED ESOPHAGITIS | GASTRIC PENTADECAPEPTIDE | BPC 157 | WOUNDS | PHARMACOLOGY & PHARMACY | Inflammatory Bowel Diseases - drug therapy | NG-Nitroarginine Methyl Ester - pharmacology | Anti-Ulcer Agents - therapeutic use | Nitric Oxide - biosynthesis | Rats, Wistar | Enzyme Inhibitors - pharmacology | Nitric Oxide Synthase - antagonists & inhibitors | Rats | Male | Nitric Oxide - physiology | Proteins - therapeutic use | Cutaneous Fistula - drug therapy | Animals | Arginine - pharmacology | Anesthesia | Colonic Diseases - drug therapy | Peptide Fragments - therapeutic use
Journal Article